EUVIMED · CrossrefZeitschrift
Translational Cancer Research
ISSN 2218-676X · AME Publishing Company
Neueste Artikel
TMBIM4 acts as a novel prognostic biomarker for glioblastoma and is associated with temozolomide chemoresistance
Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis
MRI-based radiomics with SHAP interpretation for preoperative prediction of upstaging in ductal carcinoma in situ: a comparative study of intratumoral, peritumoral, habitat, and fusion models
A weakly supervised deep learning model for OSCC diagnosis and lesion highlighting in histopathology images
Development and validation of a predictive model for perioperative venous thromboembolism in colorectal cancer patients based on D-dimer combined with fibrinogen levels
Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials
Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study
Single-cell analysis identifies a tumor-specific T-cell metabolic signature: prognostic model and association with immunosuppressive microenvironment in ovarian cancer
Artificial intelligence in radiation treatment planning: a narrative review from automation to clinical decision support
Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies—a narrative review
Targeting “undruggable” cancer proteins: pharmacological challenges and emerging strategies
Development and multicenter validation of an immunoinflammatory marker-MRI model for pathological complete response after neoadjuvant chemotherapy in invasive breast cancer
Precision, prevention and progress: charting two decades of change in gynaecological oncology—a narrative review
The double-edged sword of tumor-targeted treatment: the influence of targeted therapy on the heart
Mitochondrial gene APOO reprograms lipid metabolism to influence the prognosis of breast cancer
Immune profiling in residual disease: refining risk stratification after neoadjuvant therapy in HER2-positive breast cancer
Triglyceride-to-glucose index and lymphocyte-to-monocyte ratio enhance prognostic accuracy for colorectal cancer patients: a multicenter machine learning cohort study
High expression of TMEM119 predicts a poor prognosis in gastric cancer
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune microenvironment
Prediction of overall survival in patients with hepatocellular carcinoma and second primary malignancies: a prognostic model based on the SEER database
Introduction to animal modelling: factors and tools for choosing the optimal model for sarcoma research—a comprehensive literature review
Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2 targeted microbubble-based ultrasound molecular imaging
PHGDH knockdown activates autophagic flux to suppress migration and invasion of gastric cancer cells
Interpretable LASSO-Cox model: Hsp90α/albumin ratio predicts hepatocellular carcinoma prognosis
Targeting the METTL3/PCNA axis with STM2457 overcomes cisplatin resistance in osteosarcoma
An updated review on systemic therapy for brain metastases in non-small cell lung cancer
Prognostic implications of a programmed cell death-related long non-coding RNA signature and its relevance to immune features in esophageal carcinoma
Translating NSABP B-51 findings into practice: rethinking regional nodal irradiation in breast cancer
PM2.5 promotes non-small cell lung cancer tumorigenesis by miR-21-5p targeting PDE4DIP accumulated
A new combined prognostic model involving SLC44A4 improves the predictive ability for colorectal cancer patients
EUVIMED